Some researchers use both, theorizing that BPC-157's angiogenic effects and TB-500's cell migration properties provide complementary benefits
Phase 2: Cagrilintide introduction (weeks 9-16) Once retatrutide at 2 mg is well-tolerated, introduce cagrilintide at the lowest dose
Dermatologist Consultation: Always have a diagnosis from your dermatologist to identify the deficiency, the severity of hair loss and recommend a suitable treatment plan
TB-500 (derived from thymosin 4) and GHK-Cu also have extensive published literature, although they focus on different biological mechanisms
Phase 2: Remodeling (Weeks 58) Dose: 3.2 mg, 5x per week Same per-injection amounts
Reduced Injury Recovery: Could reduce recovery time following injury, surgery, or physical exertion